Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Freddie Kibengo"'
Autor:
Hellen Nantambi, Jackson Sembera, Violet Ankunda, Ivan Ssali, Arthur Watelo Kalyebi, Gerald Kevin Oluka, Laban Kato, Bahemuka Ubaldo, Freddie Kibengo, Joseph Ssebwana Katende, Ben Gombe, Claire Baine, Geoffrey Odoch, Susan Mugaba, Obondo James Sande, The COVID-19 Immunoprofiling Team, Pontiano Kaleebu, Jennifer Serwanga
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionWe investigated whether prior SARS-CoV-2-specific IFN-γ and antibody responses in Ugandan COVID-19 pre-pandemic specimens aligned to this population's low disease severity.MethodsWe used nucleoprotein (N), spike (S), NTD, RBD, envelope,
Externí odkaz:
https://doaj.org/article/546f6a4b64e04285a89374a02f81b4d1
Autor:
Jonathan Kitonsa, Julius Kiwanuka, Zacchaeus Anywaine, Sheila Kansiime, Kenneth Katumba, Namirembe Aeron, Justin Beardsley, Freddie Kibengo, Alastair Gray, Pontiano Kaleebu, Jeremy Day
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 15, Iss 3, p e0008983 (2021)
BackgroundCryptococcal meningitis (CCM) remains one of the leading causes of mortality among HIV infected patients. Due to factors such as the severity of CCM pathology, the quality of life (QOL) of patients post-treatment is likely to be poor. Few s
Externí odkaz:
https://doaj.org/article/7e00237f36dc4369a44502d4cad03001
Autor:
Jonathan Kitonsa, Onesmus Kamacooko, Ubaldo Mushabe Bahemuka, Freddie Kibengo, Ayoub Kakande, Anne Wajja, Vincent Basajja, Alfred Lumala, Edward Ssemwanga, Robert Asaba, Joseph Mugisha, Benjamin F Pierce, Robin Shattock, Pontiano Kaleebu, Eugene Ruzagira
Publikováno v:
PLoS ONE, Vol 16, Iss 5, p e0251992 (2021)
BackgroundHealthcare workers (HCWs) are at high risk of acquiring SARS-CoV-2 and COVID-19 and may therefore be a suitable population for COVID-19 vaccine trials. We conducted a survey to evaluate willingness-to-participate in COVID-19 vaccine trials
Externí odkaz:
https://doaj.org/article/b612cbc71c1c4a71a887a2b9f28a3f8c
Autor:
Jonathan Kitonsa, Yunia Mayanja, Emmanuel Aling, Julius Kiwanuka, Juliana Namutundu, Zacchaeus Anywaine, Abu-Baker Ggayi, Freddie Kibengo, Noah Kiwanuka, Pontiano Kaleebu
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0210287 (2019)
BackgroundCryptococcal meningitis (CCM) remains a leading cause of mortality amongst HIV infected patients in sub-Saharan Africa. When patients receive recommended therapy, mortality at 10 weeks has been reported to vary between 20 to 36%. However, m
Externí odkaz:
https://doaj.org/article/5ab8f82c0dd14cd3aeceef27a26e361f
Autor:
Freddie Kibengo, Anita Kabarambi, Paddy Kafeero, Patrick Muhumuza, Maria Nakimbugwe, Anthony Ssemaganda, Colman Tayebwa, Payam Nahid, Fiona Cresswell, Felicia Chow
Publikováno v:
Tuesday, April 25.
Autor:
Freddie Kibengo, Thomas C. Quinn, Charles Ssuuna, Julia Ejang, Deogratius Ssemwanga, Sarah Kalibbala, Ronald M. Galiwango, Joseph Kagaayi, Aminah Kigozi, Maria J. Wawer, Tom Lutalo, Gertrude Nakigozi, Anthony Ndyanabo, John Bosco Wasswa, Steven J. Reynolds, Christine Watera, Ronald H. Gray, David Serwadda, Larry W. Chang, Edward Nelson Kankaka, Mary K. Grabowski, Godfrey Kigozi, Oliver Laeyendecker, Pontiano Kaleebu, Aggrey Anok
Publikováno v:
AIDS Res Hum Retroviruses
Point of care rapid recency testing for HIV-1 may be a cost-effective tool to identify recently infected individuals for incidence estimation, and focused HIV prevention through intensified contact tracing. We validated the Asante™ HIV-1 rapid rece
Autor:
Hope Grania Nakazibwe, Vincent Muturi-Kioi, Andrew Abaasa, Freddie Kibengo, Peter Hughes, Matt Price
INTRODUCTION: fishing communities continue to face a heavy burden of HIV-infection. Access to HIV prevention methods remains problematic. Provision of affordable interventions such as condoms can help, but there is limited information on consistent c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf203a5d4bbacd8b871d083f84c47004
https://researchonline.lshtm.ac.uk/id/eprint/4666955/7/Nakazibwe_etal_2022_Factors-associated-with-consistent-condom.pdf
https://researchonline.lshtm.ac.uk/id/eprint/4666955/7/Nakazibwe_etal_2022_Factors-associated-with-consistent-condom.pdf
Autor:
Eugene Ruzagira, Edward Ssemwanga, Benjamin F. Pierce, Pontiano Kaleebu, Anne Wajja, Robert Asaba, Onesmus Kamacooko, Freddie Kibengo, Paddy Kafeero, Alfred Lumala, Jonathan Kitonsa, Vincent Basajja, Robin J. Shattock, Ubaldo Bahemuka, Joseph Mugisha, Ayoub Kakande
Publikováno v:
International Journal of Environmental Research and Public Health
Volume 18
Issue 13
International Journal of Environmental Research and Public Health, Vol 18, Iss 7004, p 7004 (2021)
Volume 18
Issue 13
International Journal of Environmental Research and Public Health, Vol 18, Iss 7004, p 7004 (2021)
Healthcare workers (HCWs) are at high risk of COVID-19. However, data on HCWs’ knowledge, attitudes, and practices (KAP) toward COVID-19 are limited. Between September and November 2020, we conducted a questionnaire-based COVID-19 KAP survey among
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a4b21e907434c466ad272c1ae8ade3b
Autor:
Vincent Basajja, Eugene Ruzagira, Ubaldo Bahemuka, Pontiano Kaleebu, Anne Wajja, Jonathan Kitonsa, Robert Asaba, Edward Ssemwanga, Freddie Kibengo, Onesmus Kamacooko, Ayoub Kakande, Benjamin F. Pierce, Joseph Mugisha, Robin J. Shattock, Alfred Lumala
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 5, p e0251992 (2021)
PLoS ONE, Vol 16, Iss 5, p e0251992 (2021)
Background Healthcare workers (HCWs) are at high risk of acquiring SARS-CoV-2 and COVID-19 and may therefore be a suitable population for COVID-19 vaccine trials. We conducted a survey to evaluate willingness-to-participate in COVID-19 vaccine trials
Autor:
Martin Onyango, Julius Kiwanuka, Yunia Mayanja, Jonathan Kitonsa, Abu-Baker Ggayi, Yofesi Nikweri, Freddie Kibengo, Rebecca N Nsubuga, Zacchaeus Anywaine, Jeremy N. Day, Pontiano Kaleebu
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 14, Iss 11, p e0008823 (2020)
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases
Globally, early initiation of antiretroviral therapy for HIV led to a reduction in the estimated mortality from cryptococcal meningitis (CCM) from 624,700 in 2009 to 181,100 in 2014. However, CCM remains one of the leading causes of mortality among H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1acc9c9e850dbda5dfd93f7c27168fe6
https://doi.org/10.1371/journal.pntd.0008823
https://doi.org/10.1371/journal.pntd.0008823